Genus Drug Patent Portfolio
Genus owns 1 orange book drug protected by 3 US patents Given below is the list of Genus's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8734847 | Formulation of indomethacin | 23 Apr, 2030 | Active |
| US8992982 | Formulation of indomethacin | 23 Apr, 2030 | Active |
| US9089471 | Formulation of indomethacin | 23 Apr, 2030 | Active |
Latest Legal Activities on Genus's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Genus.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| 7.5 yr surcharge - late pmt w/in 6 mo, Small Entity | 07 Feb, 2023 | US9089471 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 07 Feb, 2023 | US9089471 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 06 Feb, 2023 | US9089471 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 30 Sep, 2022 | US8992982 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 01 Dec, 2021 | US8734847 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 28 Jan, 2019 | US9089471 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 01 Oct, 2018 | US8992982 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 27 Nov, 2017 | US8734847 |
|
Application ready for PDX access by participating foreign offices
Critical
| 31 Aug, 2015 | US9089471 |
|
Application ready for PDX access by participating foreign offices
Critical
| 31 Aug, 2015 | US8992982 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Jul, 2015 | US9089471 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Jul, 2015 | US9089471 |
| Post Issue Communication - Certificate of Correction | 18 Jul, 2015 | US8992982 |
|
Email Notification
Critical
| 09 Jul, 2015 | US9089471 |
|
Issue Notification Mailed
Critical
| 08 Jul, 2015 | US9089471 |
Genus's Family Patents
Genus Drug List
Given below is the complete list of Genus's drugs and the patents protecting them.
1. Tivorbex
Tivorbex is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8734847 | Formulation of indomethacin |
23 Apr, 2030
(4 years from now)
| Active |
| US8992982 | Formulation of indomethacin |
23 Apr, 2030
(4 years from now)
| Active |
| US9089471 | Formulation of indomethacin |
23 Apr, 2030
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tivorbex's drug page